WT1 peptide vaccine in Montanide in contrast to poly ICLC, is able to induce WT1-specific immune response with TCR clonal enrichment in myeloid leukemia.

about

WT1 peptide vaccine in Montanide in contrast to poly ICLC, is able to induce WT1-specific immune response with TCR clonal enrichment in myeloid leukemia.

Item

http://www.wikidata.org/entity/Q48222390

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

WT1 peptide vaccine in Montani ...... nrichment in myeloid leukemia.

@en

WT1 peptide vaccine in Montani ...... nrichment in myeloid leukemia.

@nl

type

Item

label

WT1 peptide vaccine in Montani ...... nrichment in myeloid leukemia.

@en

WT1 peptide vaccine in Montani ...... nrichment in myeloid leukemia.

@nl

prefLabel

WT1 peptide vaccine in Montani ...... nrichment in myeloid leukemia.

@en

WT1 peptide vaccine in Montani ...... nrichment in myeloid leukemia.

@nl

P1476

WT1 peptide vaccine in Montani ...... nrichment in myeloid leukemia.

@en

P2093

Andres M Salazar

http://www.w3.org/2001/XMLSchema#string

Gregory Malnassy

http://www.w3.org/2001/XMLSchema#string

Jae-Hyun Park

http://www.w3.org/2001/XMLSchema#string

Margaret Green

http://www.w3.org/2001/XMLSchema#string

Noreen Fulton

http://www.w3.org/2001/XMLSchema#string

Noura Choudhury

http://www.w3.org/2001/XMLSchema#string

Olatoyosi Odenike

http://www.w3.org/2001/XMLSchema#string

Richard A Larson

http://www.w3.org/2001/XMLSchema#string

Thomas F Gajewski

http://www.w3.org/2001/XMLSchema#string

Wendy Stock

http://www.w3.org/2001/XMLSchema#string

P2860

TLR signaling

A multi-institution phase II study of poly-ICLC and radiotherapy with concurrent and adjuvant temozolomide in adults with newly diagnosed glioblastoma.

Repeated PR1 and WT1 peptide vaccination in Montanide-adjuvant fails to induce sustained high-avidity, epitope-specific CD8+ T cells in myeloid malignancies.

Combination immunotherapy after ASCT for multiple myeloma using MAGE-A3/Poly-ICLC immunizations followed by adoptive transfer of vaccine-primed and costimulated autologous T cells.

Leukemia-associated antigen-specific T-cell responses following combined PR1 and WT1 peptide vaccination in patients with myeloid malignancies.

Translational mini-review series on vaccines: Peptide vaccines for myeloid leukaemias.

Transferred WT1-reactive CD8+ T cells can mediate antileukemic activity and persist in post-transplant patients.

WT1-specific T cell receptor gene therapy: improving TCR function in transduced T cells.

Antigens for cancer immunotherapy.

Intratumoral expression levels of PD-L1, GZMA, and HLA-A along with oligoclonal T cell expansion associate with response to nivolumab in metastatic melanoma.

P2888

s40164-018-0093-x

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S40164-018-0093-X

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Hongtao Liu

P577

2018-01-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1100315844

http://www.w3.org/2001/XMLSchema#string

P698

29344432

http://www.w3.org/2001/XMLSchema#string

P932

5765712

http://www.w3.org/2001/XMLSchema#string